CIBC Bank USA’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q3
Sell
-12,965
Closed -$120K 283
2019
Q2
$120K Buy
+12,965
New +$120K 0.02% 259
2018
Q4
Sell
-9,965
Closed -$215K 264
2018
Q3
$215K Sell
9,965
-1,121
-10% -$24.2K 0.03% 238
2018
Q2
$270K Buy
+11,086
New +$270K 0.04% 206
2017
Q1
Sell
-6,490
Closed -$235K 271
2016
Q4
$235K Sell
6,490
-1,002
-13% -$36.3K 0.03% 227
2016
Q3
$345K Buy
7,492
+522
+7% +$24K 0.05% 191
2016
Q2
$350K Buy
6,970
+1,449
+26% +$72.8K 0.05% 173
2016
Q1
$295K Buy
5,521
+342
+7% +$18.3K 0.05% 172
2015
Q4
$340K Sell
5,179
-165
-3% -$10.8K 0.06% 182
2015
Q3
$302K Buy
5,344
+1,387
+35% +$78.4K 0.06% 190
2015
Q2
$235K Buy
3,957
+230
+6% +$13.7K 0.04% 237
2015
Q1
$231K Sell
3,727
-529
-12% -$32.8K 0.04% 234
2014
Q4
$245K Buy
+4,256
New +$245K 0.04% 253